Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Aug 31, 2025 | (Q1)May 31, 2025 | (FY)Feb 28, 2025 | (FY)Nov 30, 2024 | (Q4)Nov 30, 2024 | (Q3)Aug 31, 2024 | (Q2)May 31, 2024 | (Q1)Feb 29, 2024 | (FY)Nov 30, 2023 | (Q4)Nov 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -29.95%2.34M | 46.44%4.38M | 38.80%18.89M | 15.54%13.61M | 39.46%3.96M | -6.18%3.33M | -4.09%3.33M | 55.86%2.99M | 16.94%11.78M | -10.89%2.84M |
| Operating revenue | -29.95%2.34M | 46.44%4.38M | 38.80%18.89M | 15.54%13.61M | 39.46%3.96M | -6.18%3.33M | -4.09%3.33M | 55.86%2.99M | 16.94%11.78M | -10.89%2.84M |
| Cost of revenue | -47.35%1.53M | 2.49%2.5M | 174.55%11.81M | -47.39%4.3M | -56.49%1.56M | -25.09%1.82M | -2.61%2.9M | 36.06%2.44M | 15.20%8.17M | 36.03%3.59M |
| Gross profit | 85.87%809.51K | 240.10%1.88M | -23.89%7.09M | 158.11%9.31M | 421.88%2.4M | 35.27%1.5M | -12.93%435.53K | 334.46%552.64K | 21.09%3.61M | -235.32%-745.79K |
| Operating expense | -318.19%-3.11M | -5.31%1.07M | 2.34%6.36M | 31.72%6.21M | 55.23%2.45M | -102.08%-3.22M | 42.69%1.43M | 2.89%1.13M | 6.70%4.72M | -61.92%1.58M |
| Selling and administrative expenses | -1.91%1.21M | -7.98%882.87K | 4.50%5.77M | 36.06%5.52M | 62.34%2.29M | 25.42%1.04M | 38.80%1.23M | 4.82%959.4K | 3.20%4.06M | 22.92%1.41M |
| -Selling and marketing expense | --0 | ---- | 0.00%6.39K | -22.73%6.39K | 2.06%3.56K | 8.00%2.59K | --0 | -89.90%241 | -82.57%8.27K | 40.04%3.49K |
| -General and administrative expense | -1.91%1.21M | -7.95%882.87K | 4.50%5.76M | 36.18%5.51M | 62.49%2.28M | 25.47%1.04M | 38.80%1.23M | 5.07%959.16K | 4.25%4.05M | 22.88%1.4M |
| Research and development costs | --0 | 489.07%2.48K | 20.73%1.46K | -98.32%1.21K | --0 | --0 | -94.66%790 | -92.36%421 | 766.29%71.9K | 370.30%39.04K |
| Depreciation amortization depletion | -2.25%143.68K | 8.03%94.45K | -28.32%321.06K | 3.71%447.92K | 4.87%89.83K | -7.97%123.66K | 122.58%146.99K | -40.04%87.43K | 31.26%431.89K | 115.18%85.67K |
| -Depreciation and amortization | -2.25%143.68K | 8.03%94.45K | -28.32%321.06K | 3.71%447.92K | 4.87%89.83K | -7.97%123.66K | 122.58%146.99K | -40.04%87.43K | 31.26%431.89K | 115.18%85.67K |
| Other taxes | 148.28%9.09K | -87.11%5.83K | 4.38%35.77K | 141.21%34.27K | 128.73%4.5K | -85.87%3.39K | -418.03%-18.82K | --45.2K | 5.14%14.21K | -23.64%-15.68K |
| Other operating expenses | -7,182.68%-4.48M | 127.94%83.48K | 10.80%230.68K | 47.87%208.2K | 15.43%73.09K | -69.14%-4.38M | 166.52%63.22K | 18.93%36.62K | 2.23%140.8K | -97.87%63.32K |
| Operating profit | 495.69%3.92M | 240.60%810.45K | -76.47%729.28K | 379.70%3.1M | 97.74%-52.57K | 74.62%4.72M | -98.33%-991.41K | 40.59%-576.43K | 23.07%-1.11M | 35.37%-2.33M |
| Net non-operating interest income (expenses) | 16.25%-463.04K | -32.37%-461.19K | -16.88%-2.22M | -78.38%-1.9M | -66.66%-566.17K | -102.61%-428.08K | -101.14%-552.9K | -45.67%-348.41K | -39.87%-1.06M | -191.92%-339.73K |
| Non-operating interest income | -4.56%17.52K | 69.97%22.15K | 44.63%65.1K | 225.91%45.01K | -91.95%3.04K | --10.59K | --18.35K | --13.03K | --13.81K | --37.76K |
| Non-operating interest expense | -15.88%480.56K | 33.72%483.34K | 17.52%2.28M | 80.27%1.94M | 50.79%569.22K | 107.62%438.67K | 107.81%571.25K | 51.12%361.45K | 41.69%1.08M | 224.36%377.49K |
| Other net income (expenses) | 159.04%15.27K | 195.12%265.75K | -249.98%-1.19M | 82.73%-338.77K | 99.90%-1.96K | -31.56K | -25.86K | -279.39K | -1,237.11%-1.96M | -315.04%-1.96M |
| Gain on sale of security | ---- | ---- | -816.26%-401.59K | ---43.83K | ---1.96K | ---7.16K | ---7.99K | ---26.72K | ---- | ---- |
| Special income (charges) | 185.44%15.27K | 205.17%265.75K | -165.83%-784.05K | 84.96%-294.94K | --0 | ---24.4K | ---17.87K | ---252.68K | -761.59%-1.96M | -462.65%-1.96M |
| -Less:Impairment of capital assets | ---- | ---- | ---244.48K | --0 | --0 | ---- | ---- | ---- | --2.18M | --2.18M |
| -Less:Other special charges | -185.44%-15.27K | -272.21%-265.75K | 2,518.14%704.45K | 86.45%-29.13K | ---- | --24.4K | --17.87K | ---71.4K | 27.49%-214.95K | -161.67%-214.95K |
| -Less:Write off | --0 | --0 | 0.00%324.07K | --324.07K | --0 | --0 | --0 | --324.07K | --0 | --0 |
| Income before tax | 321.32%3.48M | 151.07%615.01K | -408.88%-2.67M | 120.93%865K | 86.58%-620.7K | 70.98%4.26M | -102.67%-1.57M | 0.43%-1.2M | -103.77%-4.13M | -10.48%-4.63M |
| Income tax | ||||||||||
| Earnings from equity interest net of tax | ||||||||||
| Net income | 321.32%3.48M | 151.07%615.01K | -408.88%-2.67M | 120.93%865K | 86.58%-620.7K | 70.98%4.26M | -102.67%-1.57M | 0.43%-1.2M | -103.77%-4.13M | -10.48%-4.63M |
| Net income continuous operations | 321.32%3.48M | 151.07%615.01K | -408.88%-2.67M | 120.93%865K | 86.58%-620.7K | 70.98%4.26M | -102.67%-1.57M | 0.43%-1.2M | -103.77%-4.13M | -10.48%-4.63M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 321.32%3.48M | 151.07%615.01K | -408.88%-2.67M | 120.93%865K | 86.58%-620.7K | 71.83%4.26M | -102.67%-1.57M | 0.43%-1.2M | -103.77%-4.13M | -10.49%-4.63M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | 321.32%3.48M | 151.07%615.01K | -408.88%-2.67M | 120.93%865K | 86.58%-620.7K | 71.83%4.26M | -102.67%-1.57M | 0.43%-1.2M | -103.77%-4.13M | -10.49%-4.63M |
| Diluted earnings per share | 300.00%0.02 | 0 | -300.00%-0.02 | 133.33%0.01 | 0 | 50.00%0.03 | 0.00%-0.01 | 0.00%-0.01 | -50.00%-0.03 | 0.00%-0.04 |
| Basic earnings per share | 300.00%0.02 | 0 | -300.00%-0.02 | 133.33%0.01 | 0 | 50.00%0.03 | 0.00%-0.01 | 0.00%-0.01 | -50.00%-0.03 | 0.00%-0.04 |
| Dividend per share | ||||||||||
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.